| Literature DB >> 19597568 |
Christiane Trösse1, Rune Waagbø, Olav Breck, Anne-Kristin Stavrum, Kjell Petersen, Pål A Olsvik.
Abstract
PURPOSE: Elevated levels of dietary histidine have previously been shown to prevent or mitigate cataract formation in farmed Atlantic salmon (Salmo salar L). The aim of this study was to shed light on the mechanisms by which histidine acts. Applying microarray analysis to the lens transcriptome, we screened for differentially expressed genes in search for a model explaining cataract development in Atlantic salmon and possible markers for early cataract diagnosis.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19597568 PMCID: PMC2709424
Source DB: PubMed Journal: Mol Vis ISSN: 1090-0535 Impact factor: 2.367
Transcript names, short names, accession numbers, primer sequences, amplicon sizes, and fold change expression values obtained by microarray and qRT–PCR for selected transcripts.
| 40S ribosomal protein S20 | GCAGACCTTATCCGTGGAGCTA | TGGTGATGCGCAGAGTCTTG | 85 | ||||
| HSP90-beta | CTCTGGGATGAGCTCCTCACA | CCTTTGACCTCTTTGAGAACAAGAA | 98 | ||||
| Elongation factor 1AA | CCCCTCCAGGACGTTTACAAA | CACACGGCCCACAGGTACA | 57 | ||||
| Elongation factor 1AB | TGCCCCTCCAGGATGTCTAC | CACGGCCCACAGGTACTG | 59 | ||||
| Metallothionein B | TGAATAAAGAAGCGCGATCAAA | CTGGTGCATGCGCAGTTG | 111 | 1.8 | 1.5* | ||
| Fatty acid binding protein | TTACGGAAGGTGCTGGATTC | GGGCATCAATGTGATGAAGA | 108 | −2.2 | −2.5* | ||
| Gamma crystallin M2 | GGAGAAGATGTCACGGTGGT | CCCCCTACAGAGGAGCCTAC | 125 | −1.8 | −1.8* | ||
| Ependymin precursor | TCCAGTTTAGCGTCCTGACA | GACAAGACCGGCTGGATACT | 104 | −1.7 | −2.3* | ||
| Fructose-bisphosphate aldolase B | CCTGTGTGGTCATCTCTCCAT | TGACAAGGGTGTCCTCTTCC | 116 | −1.7 | −1.1 | ||
| Sodium/potassium-transporting ATPase subunit alpha-1 precursor | AGGGAGACGTACTACTAGAAAGCAT | CAGAACTTAAAATTCCGAGCAGCAA | 85 | 1.4 | 1.5* | ||
| Calpain small subunit 1 | AGGCACCCAATGAAGTTGTC | CTCAGGGCTCATCTCCTCAC | 144 | 1.4 | 1.5* | ||
| Glyceraldehyde-3-phosphate dehydrogenase | GGTATCCCTTCATGGGTCCT | CGTGTCAGTGGTGGACCTAA | 104 | 1.2 | 1.8* | ||
| Ubiquitin-conjugating enzyme E2 D4 | CATTGCATACTTTTGAGTCCAATC | ACCCAGATGACCCCCTAGTC | 101 | −1.3 | −1.4* | ||
| Cold-inducible RNA-binding protein | TGAGCTTCGACACCACAGAG | ACGAGACCTTCCCGTTTCTT | 104 | 1.3 | 1.1 | ||
| Peroxiredoxin-6 | TCAGGGATGTTTGGAGGAAC | GGGGCGTAACTTTGATGAGA | 126 | −1.2 | −1.1 | ||
| SPARC precursor | CCAAGGCGATGTACTTGTCA | GGTTCCTGTCCCACACAGAG | 117 | 1.3 | 1.3* | ||
| Lens fiber membrane intrinsic protein | CCAGGAAGTTCACCGTCACT | TAATCGCAGGCATTCTCTCC | 147 | −1.3 | −1.3* | ||
| Heat shock cognate 70 kDa protein | ACCTCGTTGCACTTCTCCAG | GCAGCGTGACAAGGTCTCTT | 138 | 1.2 | 1.2* | ||
| Ferritin. heavy subunit | GTGTGGGTCGTTGTGTTCAG | AGTGGGGTAGTGGTGTGGAG | 110 | 1.2 | −1 | ||
| Phospholipid hydroperoxide glutathione peroxidase. mitochondrial precursor | GGCTGTTCCTTCATCCACTT | GCCAGGTACAGAGGTGGAAA | 126 | 1.2 | 1.1 |
The first four rows in the table contain the selected reference genes that are not differentially expressed in lenses from the different dietary groups. Expression of the 16 transcripts in the subsequent rows was significantly different between the dietary groups when analyzed by microarray and SAM, but only 11 of the transcripts were significantly different when analyzed by qRT–PCR analysis and Mann–Whitney test (FCs are marked with an asterisk in the table).
Figure 1Cataract scores in selected dietary groups throughout the experimental period. The cataract score for each dietary group is given as the mean of the sums of the scores for both eyes, resulting in a possible maximum score of 8 (4 for each lens). Error bars show the standard error of the mean (SEM). The number of fish per group (n) varied from 31 to 113.
Figure 2Individual cataract scores and N-acetyl histidine (NAH) concentrations in lenses of the fish used for microarray analysis. The right lens of the fish was used for microarray analysis, and thus the cataract scores (on a scale from 0 to 4) of the right lens are presented in the graphs. The NAH concentrations were determined in the left lens of the same fish. A: Cataract scores and NAH concentrations for the individual samples are shown in this graph. Under the sample names, the sample clustering (obtained by hierarchical clustering of genes and samples, see Figure 4) is shown to relate individual cataract scores and NAH concentrations to gene expression patterns (the closer the samples are in the cluster tree, the more similar is the lens transcriptome). B: Lens NAH concentrations were significantly negatively correlated to the cataract scores of the right lens (Spearman rank test; r=−0.63, p<0.002, n=22).
Figure 4Hierarchical clustering of samples and transcripts. The samples are arranged in columns, and the transcripts are arranged in rows. Only the transcripts with a q-value of 0% in the SAM list were clustered. Negative log intensity ratios are shown in green and positive log intensity ratios are shown in red in the heat map as indicated by the color bar. The blue color represents missing values. The transcripts divide into two distinct clusters. The first cluster contains the transcripts that are up-regulated in the low-His group compared to the medium-His group and is marked by a red bar at the right side of the heat map. The second cluster contains the down-regulated transcripts and is marked by a green bar at the right side of the heat map. The samples divide into three main clusters, reflecting the His feeding regimes. Low-His samples are clearly separated from medium-His samples.
Figure 3Correspondence analysis plot. The principal components 1 and 2, which explain the highest amounts of variance in the data set, are shown on the x- and y-axis of the plot, respectively. The samples are colored according to the dietary groups. The low-His samples (LLL) are blue, and the medium-His samples (MMM) are dark red. The dark red and blue lines are plotted from the point of origin through the respective group medians, which are marked by an equally colored dot. The total variance retained in the plot is 16.349%, the x-axis component variance is 10.623%, and the y-axis component variance is 5.726%.
SAM ranked gene list.
| 1 | Metallothionein B | −7.557 | −2.868 | 1.757 | 0 | L | |
| 2 | PREDICTED: similar to POMT2 [Danio rerio] | 5.977 | 2.89 | −1.907 | 0 | L | |
| 3 | UNKNOWN | 5.144 | 2.66 | −1.855 | 0 | E | |
| 4 | Metallothionein B | −5.119 | −2.649 | 1.58 | 0 | E | |
| 5 | Lipocalin precursor | 4.976 | 2.521 | −1.666 | 0 | E | |
| 6 | Fatty acid-binding protein. intestinal | 4.875 | 2.439 | −2.403 | 0 | L | |
| 7 | Fatty acid-binding protein. intestinal | 4.766 | 2.382 | −2.539 | 0 | L | |
| 8 | Lipocalin precursor | 4.564 | 2.33 | −1.639 | 0 | L | |
| 9 | Protein S100-B | 4.539 | 2.293 | −1.579 | 0 | L | |
| 10 | Cytochrome c oxidase subunit 3 | −4.529 | −2.528 | 1.504 | 0 | L | |
| 11 | Metallothionein B | −4.493 | −2.447 | 1.549 | 0 | L | |
| 12 | Lipocalin precursor | 4.439 | 2.256 | −1.527 | 0 | E | |
| 13 | Betaine aldehyde dehydrogenase | 4.406 | 2.225 | −1.824 | 0 | L | |
| 14 | UNKNOWN | −4.403 | −2.385 | 1.638 | 0 | L | |
| 15 | UNKNOWN | 4.387 | 2.194 | −1.951 | 0 | E | |
| 16 | Fatty acid-binding protein. intestinal | 4.361 | 2.167 | −2.247 | 0 | L | |
| 17 | Fatty acid-binding protein. intestinal | 4.328 | 2.142 | −2.372 | 0 | L | |
| 18 | Fatty acid-binding protein. intestinal | 4.297 | 2.119 | −2.156 | 0 | L | |
| 19 | Metallothionein A | −4.276 | −2.336 | 1.487 | 0 | L | |
| 20 | B-cell linker protein | 4.275 | 2.098 | −1.604 | 0 | L | |
| 21 | Metallothionein B | −4.218 | −2.294 | 1.512 | 0 | L | |
| 22 | Trafficking protein particle complex subunit 3 | 4.213 | 2.079 | −1.6 | 0 | L | |
| 23 | UNKNOWN | 4.2 | 2.06 | −2 | 0 | L | |
| 24 | Excluded (Chimera) | 4.196 | 2.044 | −1.433 | 0 | L | |
| 25 | Gamma crystallin M2 | 4.192 | 2.028 | −1.544 | 0 | L | |
| 26 | UNKNOWN | 4.172 | 2.013 | −1.669 | 0 | L | |
| 27 | UNKNOWN | −4.163 | −2.258 | 1.713 | 0 | E | |
| 28 | Apolipoprotein Eb precursor | −4.161 | −2.225 | 1.818 | 0 | L | |
| 29 | Apolipoprotein Eb precursor | −4.07 | −2.195 | 2.113 | 0 | E | |
| 30 | CD9 antigen | 4.068 | 1.998 | −1.866 | 0 | L | |
| 31 | UNKNOWN | 4.062 | 1.985 | −1.736 | 0 | L | |
| 32 | Chromodomain-helicase-DNA-binding protein 2 | 4.059 | 1.971 | −1.74 | 0 | L | |
| 33 | UNKNOWN | 4.045 | 1.958 | −1.573 | 0 | L | |
| 34 | SH3 domain-binding glutamic acid-rich-like protein | 4.039 | 1.946 | −1.528 | 0 | L | |
| 35 | Putative polypeptide N-acetylgalactosaminyltransferase-like protein 4 | 4.022 | 1.935 | −1.461 | 0 | L | |
| 36 | PREDICTED: similar to calmodulin-dependent phosphodiesterase [Danio rerio] | 3.961 | 1.924 | −1.81 | 0 | L | |
| 37 | Proactivator polypeptide precursor | −3.888 | −2.169 | 1.396 | 0 | E | |
| 38 | Ependymin precursor | 3.868 | 1.913 | −1.684 | 0 | E | |
| 39 | Calcium-regulated heat stable protein 1 | 3.867 | 1.902 | −1.952 | 0 | L | |
| 40 | pigment epithelium-derived factor [Paralichthys olivaceus] >gi|71063313|gb|AAZ22324.1| pigment epithelium-derived factor [Paralichthys olivaceus] | 3.866 | 1.892 | −1.625 | 0 | L | |
| 41 | Clusterin precursor | −3.863 | −2.145 | 1.698 | 0 | L | |
| 42 | UNKNOWN | 3.852 | 1.883 | −1.47 | 0 | L | |
| 43 | UNKNOWN | −3.841 | −2.123 | 1.751 | 0 | L | |
| 44 | UNKNOWN | 3.832 | 1.875 | −1.612 | 0 | L | |
| 45 | Protein FAM44B | 3.795 | 1.865 | −1.72 | 0 | L | |
| 46 | Cytochrome c oxidase subunit 3 | −3.745 | −2.103 | 1.433 | 0 | L | |
| 47 | Meprin A subunit alpha precursor | 3.744 | 1.855 | −1.738 | 0 | L | |
| 48 | Fructose-bisphosphate aldolase B | 3.74 | 1.847 | −1.674 | 0 | L | |
| 49 | Glycylpeptide N-tetradecanoyltransferase 1 | 3.717 | 1.839 | −1.719 | 0 | E | |
| 50 | Keratin. type II cytoskeletal 8 | −3.716 | −2.086 | 1.533 | 0 | L | |
| 51 | UNKNOWN | 3.709 | 1.83 | −1.796 | 0 | L | |
| 52 | Salvelinus alpinus metallothionein B gene. introns 1 and 2 and partial cds | −3.708 | −2.068 | 1.376 | 0 | L | |
| 53 | Thymosin beta-12 | −3.674 | −2.052 | 1.504 | 0 | L | |
| 54 | UNKNOWN | 3.663 | 1.822 | −1.828 | 0 | L | |
| 55 | Sodium/potassium-transporting ATPase subunit alpha-1 precursor | −3.66 | −2.036 | 1.409 | 0 | L | |
| 56 | Gamma crystallin M3 | 3.654 | 1.814 | −1.584 | 0 | L | |
| 57 | UNKNOWN | 3.653 | 1.806 | −1.776 | 0 | L | |
| 58 | UNKNOWN | 3.651 | 1.799 | −1.497 | 0 | L | |
| 59 | UNKNOWN | 3.65 | 1.792 | −1.561 | 0 | L | |
| 60 | UNKNOWN | 3.644 | 1.785 | −1.652 | 0 | L | |
| 61 | Gamma crystallin M2 | 3.643 | 1.778 | −1.825 | 0 | L | |
| 62 | Salmo salar TNF-alpha 2 gene. complete cds | 3.613 | 1.77 | −1.392 | 0 | L | |
| 63 | ATP synthase a chain | −3.603 | −2.02 | 1.298 | 0 | L | |
| 64 | UNKNOWN | 3.6 | 1.764 | −1.451 | 0 | E | |
| 65 | UNKNOWN | −3.599 | −2.006 | 1.482 | 0 | L | |
| 66 | GDP-L-fucose synthetase | −3.584 | −1.992 | 1.388 | 0 | L | |
| 67 | UNKNOWN | 3.573 | 1.757 | −1.75 | 0 | L | |
| 68 | UNKNOWN | −3.567 | −1.98 | 1.234 | 0 | L | |
| 69 | Pentraxin fusion protein precursor | 3.567 | 1.75 | −1.639 | 0 | L | |
| 70 | UNKNOWN | 3.566 | 1.743 | −1.622 | 0 | L | |
| 71 | UNKNOWN | −3.559 | −1.967 | 1.657 | 0 | L | |
| 72 | Annexin A2-A | −3.543 | −1.956 | 1.43 | 0 | L | |
| 73 | Thymosin beta-12 | −3.541 | −1.944 | 1.53 | 0 | L | |
| 74 | Calpain small subunit 1 | −3.541 | −1.932 | 1.395 | 0 | L | |
| 75 | UNKNOWN | 3.539 | 1.738 | −1.836 | 0 | L | |
| 76 | Gamma crystallin M2 | 3.538 | 1.732 | −1.321 | 0 | L | |
| 77 | Uncharacterized protein C1orf74 homolog | 3.535 | 1.725 | −1.682 | 0 | L | |
| 78 | Cytochrome c oxidase subunit 3 | −3.534 | −1.921 | 1.3 | 0 | L | |
| 79 | UNKNOWN | 3.514 | 1.719 | −1.455 | 0 | L | |
| 80 | Glyceraldehyde-3-phosphate dehydrogenase | −3.499 | −1.911 | 1.378 | 0 | L | |
| 81 | UNKNOWN | 3.47 | 1.714 | −1.928 | 0 | L | |
| 82 | Asparaginyl-tRNA synthetase. cytoplasmic | −3.47 | −1.899 | 1.39 | 0 | L | |
| 83 | Pleckstrin homology-like domain family A member 1 | 3.457 | 1.708 | −1.62 | 0 | L | |
| 84 | Cathepsin L precursor | 3.453 | 1.702 | −1.306 | 0 | L | |
| 85 | Clusterin precursor | −3.447 | −1.89 | 1.626 | 0 | L | |
| 86 | Apolipoprotein Eb precursor | −3.436 | −1.88 | 1.626 | 0 | E | |
| 87 | Oncorhynchus mykiss SYPG1 (SYPG1). PHF1 (PHF1). and RGL2 (RGL2) genes. complete cds; DNaseII pseudogene. complete sequence; LGN-like. PBX2 (PBX2). NOTCH-like. TAP1 (TAP1). and BRD2 (BRD2) genes. complete cds; and MHCII-alpha and Raftlin-like pseudogenes. complete sequence | 3.423 | 1.697 | −1.716 | 0 | L | |
| 88 | Perforin-1 precursor | 3.417 | 1.692 | −1.463 | 0 | L | |
| 89 | UNKNOWN | −3.413 | −1.871 | 1.357 | 0 | L | |
| 90 | 60S acidic ribosomal protein P1 | 3.398 | 1.687 | −1.421 | 0 | L | |
| 91 | Myosin light polypeptide 6 | −3.388 | −1.863 | 1.423 | 0 | E | |
| 92 | Gamma crystallin M2 | 3.363 | 1.681 | −1.345 | 0 | L | |
| 93 | Fructose-bisphosphate aldolase B | 3.358 | 1.676 | −1.485 | 0 | L | |
| 94 | UNKNOWN | 3.344 | 1.671 | −1.338 | 0 | L | |
| 95 | UNKNOWN | −3.34 | −1.854 | 1.273 | 0 | L | |
| 96 | Hypoxanthine-guanine phosphoribosyltransferase | 3.339 | 1.666 | −1.267 | 0 | L | |
| 97 | UNKNOWN | −3.323 | −1.845 | 1.348 | 0 | L | |
| 98 | Ubiquitin carboxyl-terminal hydrolase 32 | 3.321 | 1.661 | −1.436 | 0 | L | |
| 99 | Hexokinase-2 | 3.316 | 1.656 | −1.633 | 0 | L | |
| 100 | Cytochrome c oxidase subunit 3 | −3.312 | −1.837 | 1.334 | 0 | L | |
| 101 | Eukaryotic peptide chain release factor subunit 1 | −3.309 | −1.829 | 1.345 | 0 | L | |
| 102 | Nascent polypeptide-associated complex subunit alpha | 3.308 | 1.651 | −1.241 | 0 | L | |
| 103 | Ubiquitin-conjugating enzyme E2 D4 | 3.304 | 1.646 | −1.39 | 0 | L | |
| 104 | THO complex subunit 1 | 3.285 | 1.641 | −1.274 | 0 | L | |
| 105 | Cathepsin L precursor | −3.279 | −1.821 | 1.367 | 0 | L | |
| 106 | Gamma crystallin M2 | 3.279 | 1.636 | −1.504 | 0 | E | |
| 107 | Cytochrome b | −3.275 | −1.813 | 1.387 | 0 | L | |
| 108 | UNKNOWN | 3.274 | 1.631 | −1.37 | 0 | E | |
| 109 | Oncorhynchus mykiss G-protein (P-ras) mRNA. complete cds | 3.263 | 1.627 | −1.681 | 0 | L | |
| 110 | Cytochrome c oxidase subunit 3 | −3.259 | −1.805 | 1.403 | 0 | L | |
| 111 | Salmo salar TNF-alpha 2 gene. complete cds | 3.247 | 1.622 | −1.472 | 0 | L | |
| 112 | UNKNOWN | 3.244 | 1.618 | −1.653 | 0 | L | |
| 113 | Clusterin precursor | −3.209 | −1.798 | 1.697 | 0 | L | |
| 114 | Barrier-to-autointegration factor | 3.206 | 1.613 | −1.557 | 0 | L | |
| 115 | UNKNOWN | −3.186 | −1.791 | 1.25 | 0 | L | |
| 116 | Excluded (Chimera) | −3.185 | −1.784 | 1.63 | 0 | L | |
| 117 | UNKNOWN | −3.185 | −1.777 | 1.441 | 0 | L | |
| 118 | Cold-inducible RNA-binding protein | −3.184 | −1.77 | 1.35 | 0 | L | |
| 119 | Integral membrane protein 2C | 3.18 | 1.609 | −1.436 | 0 | L | |
| 120 | ADP-ribosylation factor 4 | 3.177 | 1.605 | −1.585 | 0 | L | |
| 121 | Ependymin precursor | 3.17 | 1.6 | −1.405 | 0 | E | |
| 122 | UNKNOWN | −3.16 | −1.763 | 1.291 | 0 | L | |
| 123 | Homo sapiens calcium homeostasis endoplasmic reticulum protein (CHERP). mRNA | −3.157 | −1.756 | 1.308 | 0 | L | |
| 124 | hyperosmotic glycine rich protein [Salmo salar] | −3.147 | −1.749 | 1.353 | 0 | L | |
| 125 | Cathepsin L2 precursor | −3.146 | −1.742 | 1.256 | 0 | L | |
| 126 | UNKNOWN | 3.146 | 1.596 | −1.282 | 0 | L | |
| 127 | UNKNOWN | −3.141 | −1.736 | 1.391 | 0 | L | |
| 128 | −3.138 | −1.73 | 1.225 | 0 | L | ||
| 129 | B-cell linker protein | 3.135 | 1.592 | −1.468 | 0 | L | |
| 130 | UNKNOWN | 3.13 | 1.588 | −1.399 | 0 | L | |
| 131 | Eukaryotic translation initiation factor 4 gamma 1 | 3.127 | 1.584 | −1.399 | 0 | L | |
| 132 | Cold-inducible RNA-binding protein | −3.122 | −1.725 | 1.297 | 0 | L | |
| 133 | UNKNOWN | 3.114 | 1.58 | −1.383 | 0 | L | |
| 134 | UNKNOWN | −3.096 | −1.718 | 1.489 | 0 | E | |
| 135 | Uncharacterized protein C8orf4 homolog | −3.095 | −1.713 | 1.53 | 0 | L | |
| 136 | UNKNOWN | 3.094 | 1.576 | −1.282 | 0 | L | |
| 137 | Beta crystallin B3 | 3.092 | 1.572 | −1.312 | 0 | L | |
| 138 | Keratin. type II cytoskeletal 8 | −3.077 | −1.706 | 1.619 | 0 | L | |
| 139 | UNKNOWN | 3.071 | 1.568 | −1.41 | 0 | L | |
| 140 | UNKNOWN | 3.055 | 1.564 | −1.327 | 0 | L | |
| 141 | Nuclear receptor 0B2 | −3.044 | −1.701 | 1.378 | 0 | E | |
| 142 | UNKNOWN | −3.038 | −1.696 | 1.271 | 0 | L | |
| 143 | UNKNOWN | −3.009 | −1.69 | 1.345 | 0 | L | |
| 144 | RAB3A-interacting protein | 3.003 | 1.561 | −1.661 | 0 | L | |
| 145 | UNKNOWN | −3.002 | −1.685 | 1.357 | 0 | L |
The transcripts shown are those with a q-value of 0% with the most significantly differentially expressed transcripts on top of the list. The complete list is given in Appendix 1. Abbreviations used in the table header are: d[i], SAM score for a transcript i; de[i], expected SAM score for a transcript i. * The term "Regulation category" in the header of the last column refers to a categorization of the transcripts determined by appearance of the graphs resulting from correlation of expression levels to individual cataract scores (see Results section). The two categories are named E (“early” regulated transcripts), and L (“late” regulated transcripts).
Figure 5Examples of transcripts with different expression patterns related to cataract score. For four selected significantly differentially expressed transcripts, the log intensity ratios are plotted against the cataract score of the respective sample, not taking into account which dietary group the samples belong to. For a certain transcript, if the difference between the mean log intensity ratios of the lenses with a score of 0 and the lenses with a score of 1 was 0.2 or greater, this transcript was classified as “early” regulated. If this difference was less than 0.2, the transcript was classified as “late” regulated. A: SPARC precursor (SPARC; CA052160) was chosen as an example for “early” up-regulated transcripts. B: Metallothionein B (MT-B; CK990996) was chosen as an example of “late” up-regulated transcripts. C: Ependymin (EPN; CA042089) was chosen as an example of “early” down-regulated transcripts. D: Fatty acid binding protein 2 (FABP2; CA054659) was chosen as an example of “late” down-regulated transcripts.
Figure 6Correlation between fold change values obtained by microarray analysis and qRT–PCR for 16 selected transcripts. Fold change (FC) values obtained by microarray analysis were significantly correlated to those obtained by qRT–PCR (Spearman rank test; r=0.89, p<0.0001, n=16).